ENTRY       D12283                      Drug
NAME        Ociperlimab (USAN/INN)
FORMULA     C6446H10008N1714O2013S46
EXACT_MASS  145108.0602
MOL_WEIGHT  145197.7017
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS DYYMYWVRQA PGKGLEWVAY ITKGGGSTYY
            PDSVKGRFTI SRDNAKNTLY LQMNSLRAED TAVYYCARQT NYDFTMDYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            EIVMTQSPAT LSVSPGERAT LSCKASQDVG TSVAWYQQKP GQAPRLLIYW ASARHTGIPA
            RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YSSYPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic, Immune checkpoint inhibitor, Anti-TIGIT receptor antibody
  TYPE      Monoclonal antibody
TARGET      TIGIT [HSA:201633] [KO:K16350]
  PATHWAY   hsa04514(201633)  Cell adhesion molecules
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D12283  Ociperlimab
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               Other
                TIGIT
                 D12283  Ociperlimab (USAN/INN)
DBLINKS     CAS: 2342597-93-5
///
